Helping Women Understand Treatment Options for Vulvar and Vaginal Atrophy

E-ISSN： 1751-486x|19|4|298-312

ISSN： 1751-4851

Source： NURSING FOR WOMENS HEALTH, Vol.19, Iss.4, 2015-08, pp. : 298-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conservative treatment options for women with stress urinary incontinence: clinical update

By Imamura Mari Jenkinson David Wallace Sheila Buckley Brian Vale Luke Pickard Robert

British Journal of General Practice, Vol. 63, Iss. 609, 2013-04 ,pp. : 218-220

Royal College of General Practitioners

Access to resources Recommend Favorite

Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention

By Pearson J Matt Feltman Richard S Twiggs Leo B

Women's Health, Vol. 4, Iss. 2, 2008-03 ,pp. : 143-150

Future Medicine

Access to resources Recommend Favorite

Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. : e39-e40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: treatment for NASH – helping the liver or helping the heart?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 487-487

John Wiley & Sons Inc

Access to resources Recommend Favorite

Misoprostol treatment vs expectant management in women with early non‐viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 51, Iss. 1, 2018-01 ,pp. : 24-32

John Wiley & Sons Inc

Access to resources Recommend Favorite